Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial

Published:2020-10 Issue:10 Volume:20 Page:1204-1214
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Ison Michael G,Portsmouth Simon,Yoshida Yuki,Shishido Takao,Mitchener Melissa,Tsuchiya Kenji,Uehara Takeki,Hayden Frederick G

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference33 articles.

1. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices-United States—2018–19 influenza season;Grohskopf;MMWR Recomm Rep,2018

2. The annual impact of seasonal influenza in the US: measuring disease burden and costs;Molinari;Vaccine,2007

3. The natural history of influenza infection in the severely immunocompromised vs nonimmunocompromised hosts;Memoli;Clin Infect Dis,2014

4. Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives;Hurt;Lancet Infect Dis,2012

5. Clinical implications of antiviral resistance in influenza;Li;Viruses,2015

Cited by 145 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Viral Infections: Overview with a focus on Prevention of Transmission;International Encyclopedia of Public Health;2025

2. Infectious Disease Updates for Primary Care;Medical Clinics of North America;2024-09

3. Detection of influenza A(H3N2) viruses with polymerase acidic subunit substitutions after and prior to baloxavir marboxil treatment during the 2022–2023 influenza season in Japan;Antiviral Research;2024-09

4. High throughput profiling identified PA-L106R amino acid substitution in A(H1N1)pdm09 influenza virus that confers reduced susceptibility to baloxavir in vitro;Antiviral Research;2024-09

5. Comparison of the Effectiveness of Baloxavir and Oseltamivir in Outpatients With Influenza B;Influenza and Other Respiratory Viruses;2024-08-27